Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 101 | $374.20M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 102 | $373.64M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 103 | $368.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 104 | $367.35M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 105 | $367.00M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 106 | $364.90M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 107 | $360.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 108 | $356.72M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 109 | $350.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 110 | $349.54M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 111 | $345.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 112 | $340.10M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 113 | $336.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 114 | $332.40M | Healthcare | Biotechnology | United States | Nasdaq |
| 115 | $330.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 116 | $319.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 117 | $319.33M | Healthcare | Pharmaceuticals | United States | NYSE |
| 118 | $306.80M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 119 | $302.52M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 120 | $300.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 121 | $300.16M | Healthcare | Medical Devices | United States | NYSE |
| 122 | $298.30M | Healthcare | Medical Devices | United States | Nasdaq |
| 123 | $292.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 124 | $292.67M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 125 | $291.34M | Healthcare | Biotechnology | United States | Nasdaq |
| 126 | $288.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 127 | $284.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 128 | $283.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 129 | $281.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 130 | $278.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 131 | $272.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 132 | $270.90M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 133 | $270.00M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 134 | $268.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 135 | $265.80M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 136 | $264.71M | Healthcare | Biotechnology | United States | Nasdaq |
| 137 | $264.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 138 | $262.30M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 139 | $258.60M | Healthcare | Pharmaceuticals | United States | NYSE |
| 140 | $257.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 141 | $256.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 142 | $255.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 143 | $249.90M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 144 | $246.68M | Healthcare | Medical Devices | United States | Nasdaq |
| 145 | $243.73M | Healthcare | Pharmaceuticals | United States | NYSE |
| 146 | $239.00M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 147 | $237.37M | Healthcare | Biotechnology | United States | Nasdaq |
| 148 | $227.91M | Healthcare | Medical Devices | United States | Nasdaq |
| 149 | $225.94M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 150 | $225.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 151 | $223.38M | Healthcare | Medical Devices | United States | NYSE |
| 152 | $222.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 153 | $221.71M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 154 | $219.11M | Healthcare | Pharmaceuticals | United States | NYSE |
| 155 | $217.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 156 | $214.70M | Healthcare | Medical Devices | United States | Nasdaq |
| 157 | $214.41M | Healthcare | Medical Devices | United States | Nasdaq |
| 158 | $214.40M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 159 | $211.61M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 160 | $206.07M | Healthcare | Medical Devices | United States | Nasdaq |
| 161 | $205.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 162 | $205.78M | Healthcare | Healthcare Providers | United States | NYSE |
| 163 | $205.27M | Healthcare | Medical Devices | United States | NYSE |
| 164 | $205.13M | Healthcare | Biotechnology | United States | Nasdaq |
| 165 | $202.64M | Healthcare | Biotechnology | United States | Nasdaq |
| 166 | $201.56M | Healthcare | Biotechnology | United States | Nasdaq |
| 167 | $200.06M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 168 | $199.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 169 | $196.93M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 170 | $196.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 171 | $196.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 172 | $195.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 173 | $193.77M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 174 | $192.03M | Healthcare | Diagnostics & Research | United States | NYSE |
| 175 | $191.46M | Healthcare | Biotechnology | United States | Nasdaq |
| 176 | $187.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 177 | $185.36M | Healthcare | Biotechnology | United States | Nasdaq |
| 178 | $184.90M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 179 | $184.31M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 180 | $183.19M | Healthcare | Biotechnology | United States | Nasdaq |
| 181 | $182.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 182 | $182.05M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 183 | $181.81M | Healthcare | Biotechnology | United States | Nasdaq |
| 184 | $181.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 185 | $179.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 186 | $179.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 187 | $179.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 188 | $177.09M | Healthcare | Medical Devices | United States | Nasdaq |
| 189 | $175.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 190 | $173.71M | Healthcare | Health Services | United States | NYSE |
| 191 | $172.80M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 192 | $171.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 193 | $171.29M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 194 | $169.87M | Healthcare | Biotechnology | United States | Nasdaq |
| 195 | $169.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 196 | $168.60M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 197 | $168.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 198 | $167.79M | Healthcare | Medical Devices | United States | Nasdaq |
| 199 | $166.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 200 | $164.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 687 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.